nach oben

Reactions Weekly

Erschienen in:

01.01.2019 | Case report

Liraglutide

Dizziness and diarrhoea: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a multicenter, open-label, observational LEAD-Ph study (NCT01345734; conducted from 1 September 2011 to 26 July 2013) of 1056 patients, two patients including a 51-year-old patient [sexes not stated; not all ages stated] were described, who developed moderate dizziness or diarrhoea during treatment with liraglutide for type 2 diabetes. …

Jimeno CA, et al. The multicenter, open-label, observational LEAD-Ph study: Real-world safety and effectiveness of liraglutide in filipino participants with type 2 diabetes. Journal of the ASEAN Federation of Endocrine Societies 33: 114-123, No. 2, 9 Oct 2018. Available from: URL: http://doi.org/10.15605/jafes.033.02.02 - Philippines

Titel: Liraglutide
Dizziness and diarrhoea: 2 case reports
Publikationsdatum: 01.01.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-57281-0

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Liraglutide

Dizziness and diarrhoea: 2 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Amphotericin-B-liposomal

Amitriptyline/quetiapine

Lymecycline

Alemtuzumab

Osimertinib

Nivolumab